FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2593272083> ?p ?o ?g. }

• W2593272083 endingPage "550" @default.
• W2593272083 startingPage "546" @default.
• W2593272083 abstract "<b>Background</b> It was the aim of this meta-analysis to assess the 12-month efficacy of intravitreal anti-vascular endothelial growth factor therapy in eyes with central retinal vein occlusion. <b>Patients and Methods</b> A MEDLINE-based survey was performed, including 33 publications (27 case series), covering a total of 1834 treated eyes. Baseline data (age, length of symptoms, visual acuity, gain in visual acuity at 3, 6, and 12 months) and average numbers of injections were calculated. Linear and non-linear regressions were calculated to relate baseline and treatment parameters and outcome. In a subgroup analysis, outcome data of randomised and non-randomised studies were compared. <b>Results</b> Mean gain in visual acuity was 2.8 ± 0.8 (mean±1 standard deviation), 2.7 ± 1.1 and 2.2 ± 1.4 lines at months 3, 6, and 12. 4.2 ± 1.2 and 6.4 ± 2.4 injections were given until months 6 and 12. Visual acuity gain improved significantly more in randomised trials (3.3 ± 0.7 and 3.0 ± 0.4, at months 6 and 12 versus 2.4 ± 1.1 and 2.2 ± 1.4, both p = 0.04) than in non-randomised studies. Eyes in randomised trials received significantly more injections (4.8 ± 1.1 and 8.6 ± 0.7 until month 6 and 12 versus 3.7 ± 1.0 and 5.6 ± 2.3, p = 0.045 and 0.04). After 12 months of care, the improvement in visual acuity was significantly correlating to the number of injections given. The dose response curve suggests saturation with treatment at an average of 7–8 injections within 12 months. The midpoint of the dose response curve was calculated at 6.78 injections per year. <b>Conclusions</b> The results of this analysis show that an improvement of approximately 3 lines can be maintained in the first year. Careful observation seems necessary to avoid under-treatment, which may occur below an average of 7–8 injections within the first 12 months of treatment." @default.
• W2593272083 created "2017-03-16" @default.
• W2593272083 creator A5010602494 @default.
• W2593272083 date "2017-03-06" @default.
• W2593272083 modified "2023-10-03" @default.
• W2593272083 title "Intravitreal anti-VEGF Treatment in Central Retinal Vein Occlusion (CRVO): a Meta-Analysis of One Year Results" @default.
• W2593272083 cites W1971399814 @default.
• W2593272083 cites W1974243302 @default.
• W2593272083 cites W1976154023 @default.
• W2593272083 cites W1979477821 @default.
• W2593272083 cites W1988606672 @default.
• W2593272083 cites W1997280360 @default.
• W2593272083 cites W199777371 @default.
• W2593272083 cites W2000150816 @default.
• W2593272083 cites W2003810812 @default.
• W2593272083 cites W2008785059 @default.
• W2593272083 cites W2011493848 @default.
• W2593272083 cites W2029586234 @default.
• W2593272083 cites W2038364050 @default.
• W2593272083 cites W2046416596 @default.
• W2593272083 cites W2047858191 @default.
• W2593272083 cites W2052204551 @default.
• W2593272083 cites W2061916858 @default.
• W2593272083 cites W2068100937 @default.
• W2593272083 cites W2078040311 @default.
• W2593272083 cites W2082208163 @default.
• W2593272083 cites W2084394581 @default.
• W2593272083 cites W2103827117 @default.
• W2593272083 cites W2113383096 @default.
• W2593272083 cites W2129223002 @default.
• W2593272083 cites W2142090310 @default.
• W2593272083 cites W2144551010 @default.
• W2593272083 cites W2150359525 @default.
• W2593272083 cites W2153879487 @default.
• W2593272083 cites W2166985747 @default.
• W2593272083 cites W2168542493 @default.
• W2593272083 cites W2172223254 @default.
• W2593272083 cites W2214801776 @default.
• W2593272083 cites W2285674438 @default.
• W2593272083 cites W2323650168 @default.
• W2593272083 cites W2324588265 @default.
• W2593272083 cites W2326434608 @default.
• W2593272083 cites W2343735819 @default.
• W2593272083 cites W2588891504 @default.
• W2593272083 cites W2767447900 @default.
• W2593272083 doi "https://doi.org/10.1055/s-0042-123057" @default.
• W2593272083 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28264222" @default.
• W2593272083 hasPublicationYear "2017" @default.
• W2593272083 type Work @default.
• W2593272083 sameAs 2593272083 @default.
• W2593272083 citedByCount "5" @default.
• W2593272083 countsByYear W25932720832017 @default.
• W2593272083 countsByYear W25932720832018 @default.
• W2593272083 countsByYear W25932720832019 @default.
• W2593272083 countsByYear W25932720832021 @default.
• W2593272083 countsByYear W25932720832023 @default.
• W2593272083 crossrefType "journal-article" @default.
• W2593272083 hasAuthorship W2593272083A5010602494 @default.
• W2593272083 hasConcept C118487528 @default.
• W2593272083 hasConcept C126322002 @default.
• W2593272083 hasConcept C141071460 @default.
• W2593272083 hasConcept C168563851 @default.
• W2593272083 hasConcept C187960798 @default.
• W2593272083 hasConcept C2776694085 @default.
• W2593272083 hasConcept C2777802072 @default.
• W2593272083 hasConcept C2778257484 @default.
• W2593272083 hasConcept C2778749236 @default.
• W2593272083 hasConcept C2778844676 @default.
• W2593272083 hasConcept C2780347916 @default.
• W2593272083 hasConcept C2781100027 @default.
• W2593272083 hasConcept C71924100 @default.
• W2593272083 hasConcept C95190672 @default.
• W2593272083 hasConceptScore W2593272083C118487528 @default.
• W2593272083 hasConceptScore W2593272083C126322002 @default.
• W2593272083 hasConceptScore W2593272083C141071460 @default.
• W2593272083 hasConceptScore W2593272083C168563851 @default.
• W2593272083 hasConceptScore W2593272083C187960798 @default.
• W2593272083 hasConceptScore W2593272083C2776694085 @default.
• W2593272083 hasConceptScore W2593272083C2777802072 @default.
• W2593272083 hasConceptScore W2593272083C2778257484 @default.
• W2593272083 hasConceptScore W2593272083C2778749236 @default.
• W2593272083 hasConceptScore W2593272083C2778844676 @default.
• W2593272083 hasConceptScore W2593272083C2780347916 @default.
• W2593272083 hasConceptScore W2593272083C2781100027 @default.
• W2593272083 hasConceptScore W2593272083C71924100 @default.
• W2593272083 hasConceptScore W2593272083C95190672 @default.
• W2593272083 hasIssue "04" @default.
• W2593272083 hasLocation W25932720831 @default.
• W2593272083 hasLocation W25932720832 @default.
• W2593272083 hasOpenAccess W2593272083 @default.
• W2593272083 hasPrimaryLocation W25932720831 @default.
• W2593272083 hasRelatedWork W1990147459 @default.
• W2593272083 hasRelatedWork W2050270337 @default.
• W2593272083 hasRelatedWork W2123096760 @default.
• W2593272083 hasRelatedWork W2518914114 @default.
• W2593272083 hasRelatedWork W2553987180 @default.
• W2593272083 hasRelatedWork W2588621177 @default.
• W2593272083 hasRelatedWork W3131125541 @default.

• next